Trial intelligence / Profile preview

NPO-11 in Chinese Patients Undergoing Gastrointestinal Endoscopy

NCT03263910Phase 3Completed

Sponsor
Nihon Pharmaceutical
Start
Aug 2017
Primary completion
Aug 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of L-menthol preparation NPO-11, sponsored by Nihon Pharmaceutical. Primary endpoint: Proportion of patients with no gastric peristalsis at 15 minutes. Started Aug 2017; status: completed.

02

Drugs

L-menthol preparation NPO-11

Beyond the preview

Go deeper on NCT03263910.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03263910.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call